Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002-2012) of different treatment regimens: The legacy of lamivudine/adefovir combination treatment.

Vincenti D, Piselli P, Solmone M, D'Offizi G, Capobianchi MR, Menzo S.

Antiviral Res. 2017 Jul;143:62-68. doi: 10.1016/j.antiviral.2017.03.008. Epub 2017 Mar 18.

PMID:
28322924
2.

Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination.

Galati G, De Vincentis A, Vespasiani-Gentilucci U, Gallo P, Vincenti D, Solmone MC, Dell'Unto C, Picardi A.

BMC Gastroenterol. 2014 May 17;14:94. doi: 10.1186/1471-230X-14-94.

3.

Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants.

Solmone M, Giombini E, Vincenti D, Rozera G, Testa A, Moscetti A, Catalano M, Abbate I, Capobianchi MR, Menzo S.

Antivir Ther. 2014;19(2):201-9. doi: 10.3851/IMP2700. Epub 2013 Nov 25.

PMID:
24275042
4.

Extent of HCV NS3 protease variability and resistance-associated mutations assessed by next generation sequencing in HCV monoinfected and HIV/HCV coinfected patients.

Bartolini B, Giombini E, Zaccaro P, Selleri M, Rozera G, Abbate I, Comandini UV, Ippolito G, Solmone M, Capobianchi MR.

Virus Res. 2013 Nov 6;177(2):205-8. doi: 10.1016/j.virusres.2013.08.001. Epub 2013 Aug 13.

PMID:
23954579
5.

Hospital cluster of HBV infection: molecular evidence of patient-to-patient transmission through lancing device.

Lanini S, Garbuglia AR, Puro V, Solmone M, Martini L, Arcese W, Nanni Costa A, Borgia P, Piselli P, Capobionchi MR, Ippolito G.

PLoS One. 2012;7(3):e33122. doi: 10.1371/journal.pone.0033122. Epub 2012 Mar 6.

6.

Combinatorial analysis and algorithms for quasispecies reconstruction using next-generation sequencing.

Prosperi MC, Prosperi L, Bruselles A, Abbate I, Rozera G, Vincenti D, Solmone MC, Capobianchi MR, Ulivi G.

BMC Bioinformatics. 2011 Jan 5;12:5. doi: 10.1186/1471-2105-12-5.

7.

Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus.

Menzo S, Vincenti D, Solmone M, Prosperi M, Bruselles A, Abbate I, Rozera G, Capobianchi MR.

J Infect Dis. 2009 Dec 1;200(11):1798-9; author reply 1799-1800. doi: 10.1086/647991. No abstract available.

PMID:
19905934
8.

Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.

Iacomi F, Vincenti D, Vairo F, Solmone M, Mariano A, Piselli P, Puro V, Capobianchi MR, Antonucci G.

J Med Virol. 2009 Jul;81(7):1151-6. doi: 10.1002/jmv.21505.

PMID:
19475624
9.

A sensitive direct sequencing assay based on nested PCR for the detection of HBV polymerase and surface glycoprotein mutations.

Vincenti D, Solmone M, Garbuglia AR, Iacomi F, Capobianchi MR.

J Virol Methods. 2009 Jul;159(1):53-7. doi: 10.1016/j.jviromet.2009.02.027. Epub 2009 Mar 9.

PMID:
19442845
10.
11.

Role of hepatitis B virus, hepatitis D virus and other determinants on suppression of hepatitis C viraemia in HIV infected patients with chronic HCV infection: a longitudinal evaluation.

Antonucci G, Vairo F, Iacomi F, Comandini UV, Solmone M, Piselli P, Boumis E, Lauria FN, Capobianchi MR, Ippolito G, Puro V.

Scand J Infect Dis. 2008;40(11-12):928-34. doi: 10.1080/00365540802275846.

PMID:
18651264
12.

Evaluation of an automated extraction system in combination with Affigene CMV Trender for CMV DNA quantitative determination: comparison with nested PCR and pp65 antigen test.

Abbate I, Finnstrom N, Zaniratti S, Solmone MC, Selvaggini S, Bennici E, Neri S, Brega C, Paterno M, Capobianchi MR.

J Virol Methods. 2008 Jul;151(1):61-5. doi: 10.1016/j.jviromet.2008.03.021. Epub 2008 May 6.

PMID:
18462815
13.

Epidemiology of viral hepatitis infections in an area of southern Italy with high incidence rates of liver cancer.

Fusco M, Girardi E, Piselli P, Palombino R, Polesel J, Maione C, Scognamiglio P, Pisanti FA, Solmone M, Di Cicco P, Ippolito G, Franceschi S, Serraino D; Collaborating Study Group.

Eur J Cancer. 2008 Apr;44(6):847-53. doi: 10.1016/j.ejca.2008.01.025. Epub 2008 Mar 4.

PMID:
18313290
14.

Comparison of Versant HBV DNA 3.0 and COBAS AmpliPrep-COBAS TaqMan assays for hepatitis B DNA quantitation: Possible clinical implications.

Garbuglia AR, Angeletti C, Lauria FN, Zaccaro P, Cocca AM, Pisciotta M, Solmone M, Capobianchi MR.

J Virol Methods. 2007 Dec;146(1-2):274-80. Epub 2007 Aug 20.

PMID:
17707918
15.

The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr.

Antonucci G, Longo MA, Angeletti C, Vairo F, Oliva A, Comandini UV, Tocci G, Boumis E, Noto P, Solmone MC, Capobianchi MR, Girardi E.

Am J Gastroenterol. 2007 Jul;102(7):1383-91. Epub 2007 Mar 31.

PMID:
17403072
16.

Trends in HIV prevalence among pregnant women in Italy, 1994 to 2002.

Girardi E, Vanacore P, Costa F, Solmone M, Angeletti C, Capobianchi MR, Ippolito G.

J Acquir Immune Defic Syndr. 2006 Mar;41(3):361-4.

PMID:
16540938
17.

Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.

Solmone M, Girardi E, Lalle E, Abbate I, D'Arminio Monforte A, Cozzi-Lepri A, Alessandrini A, Piscopo R, Ebo F, Cosco L, Antonucci G, Ippolito G, Capobianchi MR; Hepal.Co.N.A. Study Group; I.Co.N.A Study Group.

Antivir Ther. 2006;11(1):87-94.

PMID:
16518964
18.

Gamma delta T cells and resolution of cytomegalovirus infection in an HIV/HCV coinfected patient after liver transplantation.

D'Offizi G, Gioia C, Martini F, Volpi I, Solmone M, Poccia F, Narciso P, Vennarecci G, Ettore GM, Antonini M, Santoro E, Carosi G.

Transplantation. 2005 Nov 27;80(10):1523-4. No abstract available.

PMID:
16340802
19.

Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.

Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD; HepaI.Co.N.A. Study Group; Italian Cohort Naive for Antiretrovirals Study Group.

Clin Infect Dis. 2005 Jun 15;40(12):e101-9. Epub 2005 May 5.

PMID:
15909251
20.

Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals.

Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, Morsica G, Pizzaferri P, Ladisa N, Sighinolfi L, Chiodera A, Solmone M, Lalle E, Ippolito G, Monforte Ad; HepaICoNA Study Group; ICoNA Study Group.

Antivir Ther. 2005;10(1):109-17.

PMID:
15751768
21.

Influence of GB virus type C and HIV coinfection on gamma delta T cells.

Martini F, Solmone M, Agrati C, Capobianchi MR, Iacomi F, Antonucci G, Poccia F.

Clin Infect Dis. 2005 Jan 15;40(2):326-8; author reply 328-9. No abstract available.

PMID:
15655761
22.

HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin.

Abbate I, Lo Iacono O, Di Stefano R, Cappiello G, Girardi E, Longo R, Ferraro D, Antonucci G, Di Marco V, Solmone M, Craxì A, Ippolito G, Capobianchi MR.

J Hepatol. 2004 May;40(5):831-6.

PMID:
15094232
23.

Intra-hepatic messenger RNA levels for interferons and related genes in hepatitis C virus/HIV co-infected patients.

Abbate I, Cappiello G, Rosati S, Tocci G, Antonucci G, Solmone M, Longo R, Spanò A, Capobianchi MR.

AIDS. 2004 Mar 5;18(4):691-2. No abstract available. Erratum in: AIDS. 2004 Aug 20;18(12):1752.

PMID:
15090776
24.

Heterogeneity of HVR-1 quasispecies is predictive of early but not sustained virological response in genotype 1b-infected patients undergoing combined treatment with PEG- or STD-IFN plus RBV.

Abbate I, Cappiello G, Lo Iacono O, Longo R, Ferraro D, Antonucci G, Di Marco V, Di Stefano R, Craxì A, Solmone MC, Spanò A, Ippolito G, Capobianchi MR.

J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):162-5.

PMID:
14518716
25.

Contamination by hepatitis B and C viruses in the dialysis setting.

Froio N, Nicastri E, Comandini UV, Cherubini C, Felicioni R, Solmone M, Di Giulio S, Petrosillo N.

Am J Kidney Dis. 2003 Sep;42(3):546-50.

PMID:
12955683
26.

ISDR pattern and evolution in patients with chronic hepatitis C treated with standard or PEG-IFN plus ribavirin.

Cappiello G, Abbate I, Lo Iacono O, Longo R, Solmone M, Ferraro D, Antonucci G, Di Marco V, Di Stefano R, Craxi A, Ippolito G, Capobianchi MR.

Antivir Ther. 2003 Apr;8(2):105-10.

PMID:
12741622
27.

HCV and interferon: viral strategies for evading innate defence mechanisms in the virus-host battle.

Capobianchi MR, Abbate I, Cappiello G, Solmone M.

Cell Death Differ. 2003 Jan;10 Suppl 1:S22-4. Review. No abstract available.

28.

Simple and reliable method for detection and genotyping of hepatitis C virus RNA in dried blood spots stored at room temperature.

Solmone M, Girardi E, Costa F, Pucillo L, Ippolito G, Capobianchi MR.

J Clin Microbiol. 2002 Sep;40(9):3512-4.

29.

Significant reduction in HIV-1 plasma viral load but not in proviral infected cells during sub-optimal antiretroviral therapy.

Riva E, Antonelli G, Solmone MC, Turriziani O, Narciso P, Tozzi V, Dianzani F.

J Biol Regul Homeost Agents. 2000 Jan-Mar;14(1):1-3.

PMID:
10763882
30.

CD4 Lymphocyte enumeration: comparison between flow cytometry and enzyme immunoassay.

Cordiali Fei P, Solmone M, Vanacore P, Giglio A, Bonifati C, Carducci M, Mussi A, Chiarotti F, Ameglio F.

Cytometry. 1995 Mar 15;22(1):70-4.

31.

Apoptosis in HIV infection: protective role of IL-2.

Cordiali Fei P, Solmone M, Viora M, Vanacore P, Pugliese O, Giglio A, Caprilli F, Ameglio F.

J Biol Regul Homeost Agents. 1994 Apr-Jun;8(2):60-4.

PMID:
7863815
32.

Serum IL-10 levels in HIV-positive subjects: correlation with CDC stages.

Ameglio F, Cordiali Fei P, Solmone M, Bonifati C, Prignano G, Giglio A, Caprilli F, Gentili G, Capobianchi MR.

J Biol Regul Homeost Agents. 1994 Apr-Jun;8(2):48-52.

PMID:
7863812
33.

Autoreactive response in seronegative homosexual men at high risk for HIV infection.

Cordiali Fei P, Solmone M, Caprilli F, Ameglio F, Pugliese O, Quintieri F.

Viral Immunol. 1994;7(1):1-9.

PMID:
7986331
34.

Serum interleukin-6 levels as an early marker of therapeutic response to UVB radiation and topical steroids in psoriatic patients.

Bonifati C, Solmone M, Trento E, Pietravalle M, Fazio M, Ameglio F.

Int J Clin Lab Res. 1994;24(2):122-3. No abstract available.

PMID:
7919430
35.

Serum reactivity against an immunoregulatory sequence of HIV p24 in HIV-1-infected subjects.

Cordiali Fei P, Solmone M, Prignano G, Pugliese O, Viora M, Luzzati A, Ameglio F.

Viral Immunol. 1994;7(4):199-203.

PMID:
7576034

Supplemental Content

Loading ...
Support Center